Browsing Tag
US FDA
379 posts
Strides Pharma Science receives FDA approval for Pregabalin capsules
Strides Pharma Science Limited (Strides) has achieved a significant milestone in the pharmaceutical industry with the United States…
FDA approves Merck’s KEYTRUDA for advanced cervical cancer treatment
Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food…
Drug Farm’s DF-003 gets FDA rare pediatric disease designation for ROSAH Syndrome
Drug Farm, a clinical-stage biopharmaceutical company, has announced that its alpha-kinase 1 (ALPK1) inhibitor, DF-003, has been granted…
Nuvation Bio receives FDA clearance for NUV-1511 IND in advanced solid tumors
In a significant stride for cancer treatment, Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company dedicated to addressing…
AstraZeneca, Ionis Pharmaceuticals get FDA approval of Wainua for ATTRv-PN
In a major development for hereditary transthyretin-mediated amyloidosis (ATTRv-PN or hATTR-PN) patients, the US Food and Drug Administration…
Calliditas Therapeutics bags TARPEYO FDA approval for IgAN
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) has announced a landmark FDA approval for TARPEYO (budesonide) delayed…
Zydus Lifesciences gains FDA approval for Cyclophosphamide Capsules
Zydus Lifesciences Limited, a leading pharmaceutical company, has achieved a significant milestone by receiving final approval from the…
Granules India secures ANDA approval for Pantoprazole Sodium Tablets from FDA
Granules India Limited, a prominent player in the pharmaceutical industry, has announced that the US Food & Drug…
Lupin gets FDA nod for Allopurinol Tablets, eyeing share in $88m market
Global pharmaceutical company Lupin Limited has announced its receipt of approval from the United States Food and Drug…
Cipla’s InvaGen Pharmaceuticals recalls Vigabatrin over seal integrity concerns
InvaGen Pharmaceuticals Inc., a wholly-owned subsidiary of Cipla Limited, has announced a voluntary recall of one lot of…